Item 2.02. Results of Operations and Financial Condition

On July 29, 2008, SciClone Pharmaceuticals, Inc. (the "Company") issued a press release announcing its financial results for the second quarter ended June 30, 2008. A copy of the Company's press release is attached hereto as Exhibit 99.1 and incorporated herein by reference.

Item 9.01. Financial Statements and Exhibits

(a) Financial statements:
            None
(b) Pro forma financial information:
            None
(c) Shell company transactions:
            None
(d) Exhibits
            99.1       Press Release of SciClone Pharmaceuticals, Inc. dated July 29, 2008

SIGNATURE

      Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.


Dated: July 29, 2008
 SCICLONE PHARMACEUTICALS, INC.

By:  /s/ Friedhelm Blobel                    
     Friedhelm Blobel, Ph.D.
     President and Chief Executive Officer

Exhibit Index
Exhibit No. Description
99.1 Press Release of SciClone Pharmaceuticals, Inc. dated July 29, 2008